ID   PLAT3_PONAB             Reviewed;         162 AA.
AC   Q5R611;
DT   26-APR-2005, integrated into UniProtKB/Swiss-Prot.
DT   21-DEC-2004, sequence version 1.
DT   07-APR-2021, entry version 62.
DE   RecName: Full=Phospholipase A and acyltransferase 3 {ECO:0000250|UniProtKB:P53816};
DE            EC=2.3.1.- {ECO:0000250|UniProtKB:P53816};
DE            EC=3.1.1.32 {ECO:0000250|UniProtKB:P53816};
DE            EC=3.1.1.4 {ECO:0000250|UniProtKB:P53816};
DE   AltName: Full=Group XVI phospholipase A2 {ECO:0000250|UniProtKB:P53816};
DE   AltName: Full=H-rev 107 protein homolog {ECO:0000250|UniProtKB:P53816};
DE   AltName: Full=HRAS-like suppressor 3 {ECO:0000250|UniProtKB:P53816};
DE            Short=HRSL3 {ECO:0000250|UniProtKB:P53816};
GN   Name=PLAAT3 {ECO:0000250|UniProtKB:P53816};
GN   Synonyms=HRASLS3 {ECO:0000250|UniProtKB:P53816},
GN   HREV107 {ECO:0000250|UniProtKB:P53816},
GN   PLA2G16 {ECO:0000250|UniProtKB:P53816};
OS   Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Pongo.
OX   NCBI_TaxID=9601;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain cortex;
RG   The German cDNA consortium;
RL   Submitted (NOV-2004) to the EMBL/GenBank/DDBJ databases.
CC   -!- FUNCTION: Exhibits both phospholipase A1/2 and acyltransferase
CC       activities (By similarity). Shows phospholipase A1 (PLA1) and A2
CC       (PLA2), catalyzing the calcium-independent release of fatty acids from
CC       the sn-1 or sn-2 position of glycerophospholipids (By similarity). For
CC       most substrates, PLA1 activity is much higher than PLA2 activity (By
CC       similarity). Shows O-acyltransferase activity, catalyzing the transfer
CC       of a fatty acyl group from glycerophospholipid to the hydroxyl group of
CC       lysophospholipid (By similarity). Shows N-acyltransferase activity,
CC       catalyzing the calcium-independent transfer of a fatty acyl group at
CC       the sn-1 position of phosphatidylcholine (PC) and other
CC       glycerophospholipids to the primary amine of phosphatidylethanolamine
CC       (PE), forming N-acylphosphatidylethanolamine (NAPE), which serves as
CC       precursor for N-acylethanolamines (NAEs) (By similarity). Exhibits high
CC       N-acyltransferase activity and low phospholipase A1/2 activity (By
CC       similarity). {ECO:0000250|UniProtKB:P53816}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a 1,2-diacyl-sn-glycero-3-phosphocholine + H2O = a 1-acyl-sn-
CC         glycero-3-phosphocholine + a fatty acid + H(+); Xref=Rhea:RHEA:15801,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:28868,
CC         ChEBI:CHEBI:57643, ChEBI:CHEBI:58168; EC=3.1.1.4;
CC         Evidence={ECO:0000250|UniProtKB:P53816};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:15802;
CC         Evidence={ECO:0000250|UniProtKB:P53816};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a 1,2-diacyl-sn-glycero-3-phosphocholine + H2O = a 2-acyl-sn-
CC         glycero-3-phosphocholine + a fatty acid + H(+); Xref=Rhea:RHEA:18689,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:28868,
CC         ChEBI:CHEBI:57643, ChEBI:CHEBI:57875; EC=3.1.1.32;
CC         Evidence={ECO:0000250|UniProtKB:P53816};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:18690;
CC         Evidence={ECO:0000250|UniProtKB:P53816};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1,2-dihexadecanoyl-sn-glycero-3-phosphocholine + H2O = 1-
CC         hexadecanoyl-sn-glycero-3-phosphocholine + H(+) + hexadecanoate;
CC         Xref=Rhea:RHEA:41223, ChEBI:CHEBI:7896, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:72998, ChEBI:CHEBI:72999;
CC         Evidence={ECO:0000250|UniProtKB:P53816};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:41224;
CC         Evidence={ECO:0000250|UniProtKB:P53816};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1,2-dihexadecanoyl-sn-glycero-3-phosphocholine + H2O = 2-
CC         hexadecanoyl-sn-glycero-3-phosphocholine + H(+) + hexadecanoate;
CC         Xref=Rhea:RHEA:40487, ChEBI:CHEBI:7896, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:72999, ChEBI:CHEBI:76078;
CC         Evidence={ECO:0000250|UniProtKB:P53816};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:40488;
CC         Evidence={ECO:0000250|UniProtKB:P53816};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-hexadecanoyl-2-(9Z-octadecenoyl)-sn-glycero-3-phosphocholine
CC         + H2O = 2-(9Z-octadecenoyl)-sn-glycero-3-phosphocholine + H(+) +
CC         hexadecanoate; Xref=Rhea:RHEA:38783, ChEBI:CHEBI:7896,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:73001,
CC         ChEBI:CHEBI:76071; Evidence={ECO:0000250|UniProtKB:P53816};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:38784;
CC         Evidence={ECO:0000250|UniProtKB:P53816};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-hexadecanoyl-2-(9Z-octadecenoyl)-sn-glycero-3-phosphocholine
CC         + H2O = (9Z)-octadecenoate + 1-hexadecanoyl-sn-glycero-3-
CC         phosphocholine + H(+); Xref=Rhea:RHEA:38779, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:30823, ChEBI:CHEBI:72998,
CC         ChEBI:CHEBI:73001; Evidence={ECO:0000250|UniProtKB:P53816};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:38780;
CC         Evidence={ECO:0000250|UniProtKB:P53816};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-hexadecanoyl-2-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn-glycero-
CC         3-phosphocholine + H2O = (5Z,8Z,11Z,14Z)-eicosatetraenoate + 1-
CC         hexadecanoyl-sn-glycero-3-phosphocholine + H(+);
CC         Xref=Rhea:RHEA:40427, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:32395, ChEBI:CHEBI:72998, ChEBI:CHEBI:73003;
CC         Evidence={ECO:0000250|UniProtKB:P53816};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:40428;
CC         Evidence={ECO:0000250|UniProtKB:P53816};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-hexadecanoyl-2-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn-glycero-
CC         3-phosphocholine + H2O = 2-(5Z,8Z,11Z,14Z)-eicosatetraenoyl-sn-
CC         glycero-3-phosphocholine + H(+) + hexadecanoate;
CC         Xref=Rhea:RHEA:40571, ChEBI:CHEBI:7896, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:73003, ChEBI:CHEBI:76079;
CC         Evidence={ECO:0000250|UniProtKB:P53816};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:40572;
CC         Evidence={ECO:0000250|UniProtKB:P53816};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-
CC         phosphoethanolamine + H2O = (9Z,12Z)-octadecadienoate + 1-
CC         hexadecanoyl-sn-glycero-3-phosphoethanolamine + H(+);
CC         Xref=Rhea:RHEA:40815, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:30245, ChEBI:CHEBI:73004, ChEBI:CHEBI:73008;
CC         Evidence={ECO:0000250|UniProtKB:P53816};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:40816;
CC         Evidence={ECO:0000250|UniProtKB:P53816};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-
CC         phosphoethanolamine + H2O = 2-(9Z,12Z)-octadecadienoyl-sn-glycero-3-
CC         phosphoethanolamine + H(+) + hexadecanoate; Xref=Rhea:RHEA:45164,
CC         ChEBI:CHEBI:7896, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:73008, ChEBI:CHEBI:76090;
CC         Evidence={ECO:0000250|UniProtKB:P53816};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:45165;
CC         Evidence={ECO:0000250|UniProtKB:P53816};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-hexadecanoyl-2-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn-glycero-
CC         3-phosphoethanolamine + H2O = (5Z,8Z,11Z,14Z)-eicosatetraenoate + 1-
CC         hexadecanoyl-sn-glycero-3-phosphoethanolamine + H(+);
CC         Xref=Rhea:RHEA:40431, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:32395, ChEBI:CHEBI:73004, ChEBI:CHEBI:73009;
CC         Evidence={ECO:0000250|UniProtKB:P53816};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:40432;
CC         Evidence={ECO:0000250|UniProtKB:P53816};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-hexadecanoyl-2-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn-glycero-
CC         3-phosphoethanolamine + H2O = 2-(5Z,8Z,11Z,14Z)-eicosatetraenoyl-sn-
CC         glycero-3-phosphoethanolamine + H(+) + hexadecanoate;
CC         Xref=Rhea:RHEA:41348, ChEBI:CHEBI:7896, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:73009, ChEBI:CHEBI:76091;
CC         Evidence={ECO:0000250|UniProtKB:P53816};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:41349;
CC         Evidence={ECO:0000250|UniProtKB:P53816};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-hexanoyl-2-acyl-sn-glycero-3-phosphocholine + H2O = a 2-
CC         acyl-sn-glycero-3-phosphocholine + H(+) + hexanoate;
CC         Xref=Rhea:RHEA:53496, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:17120, ChEBI:CHEBI:57875, ChEBI:CHEBI:137403;
CC         Evidence={ECO:0000250|UniProtKB:P53816};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:53497;
CC         Evidence={ECO:0000250|UniProtKB:P53816};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-hexanoyl-2-acyl-sn-glycero-3-phosphocholine + H2O = 1-
CC         hexanoyl-sn-glycero-3-phosphocholine + a fatty acid + H(+);
CC         Xref=Rhea:RHEA:53500, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:28868, ChEBI:CHEBI:78215, ChEBI:CHEBI:137403;
CC         Evidence={ECO:0000250|UniProtKB:P53816};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:53501;
CC         Evidence={ECO:0000250|UniProtKB:P53816};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1,2-diheptadecanoyl-sn-glycero-3-phosphoethanolamine + 1-(9Z-
CC         octadecenoyl)-2-hexadecanoyl-sn-glycero-3-phosphocholine = 1,2-
CC         diheptadecanoyl-sn-glycero-3-phospho-N-hexadecanoyl-ethanolamine + a
CC         1-(9Z-octadecenoyl)-sn-glycero-3-phosphocholine + H(+);
CC         Xref=Rhea:RHEA:53524, ChEBI:CHEBI:15378, ChEBI:CHEBI:28610,
CC         ChEBI:CHEBI:74667, ChEBI:CHEBI:138218, ChEBI:CHEBI:138220;
CC         Evidence={ECO:0000250|UniProtKB:P53816};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:53525;
CC         Evidence={ECO:0000250|UniProtKB:P53816};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1,2-diheptadecanoyl-sn-glycero-3-phosphoethanolamine + 1-(9Z-
CC         octadecenoyl)-2-hexadecanoyl-sn-glycero-3-phosphocholine = 1,2-
CC         diheptadecanoyl-sn-glycero-3-phospho-N-(9Z-octadecenoyl)-ethanolamine
CC         + 2-hexadecanoyl-sn-glycero-3-phosphocholine + H(+);
CC         Xref=Rhea:RHEA:53528, ChEBI:CHEBI:15378, ChEBI:CHEBI:74667,
CC         ChEBI:CHEBI:76078, ChEBI:CHEBI:138218, ChEBI:CHEBI:138222;
CC         Evidence={ECO:0000250|UniProtKB:P53816};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:53529;
CC         Evidence={ECO:0000250|UniProtKB:P53816};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1,2-dihexanoyl-sn-glycero-3-phosphoethanolamine + 2-heptanoyl-
CC         sn-glycero-3-phosphocholine = 1-hexanoyl-2-heptanoyl-sn-glycero-3-
CC         phosphocholine + hexanoyl-sn-glycero-3-phosphoethanolamine;
CC         Xref=Rhea:RHEA:54544, ChEBI:CHEBI:138197, ChEBI:CHEBI:138216,
CC         ChEBI:CHEBI:138266, ChEBI:CHEBI:138267;
CC         Evidence={ECO:0000250|UniProtKB:P53816};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:54545;
CC         Evidence={ECO:0000250|UniProtKB:P53816};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-hexadecanoyl-2-octadecanoyl-sn-glycero-3-phosphocholine +
CC         H2O = 1-hexadecanoyl-sn-glycero-3-phosphocholine + H(+) +
CC         octadecanoate; Xref=Rhea:RHEA:56432, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:25629, ChEBI:CHEBI:72998,
CC         ChEBI:CHEBI:73000; Evidence={ECO:0000250|UniProtKB:P53816};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:56433;
CC         Evidence={ECO:0000250|UniProtKB:P53816};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-hexadecanoyl-2-octadecanoyl-sn-glycero-3-phosphocholine +
CC         H2O = 2-octadecanoyl-sn-glycero-3-phosphocholine + H(+) +
CC         hexadecanoate; Xref=Rhea:RHEA:56436, ChEBI:CHEBI:7896,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:73000,
CC         ChEBI:CHEBI:76076; Evidence={ECO:0000250|UniProtKB:P53816};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:56437;
CC         Evidence={ECO:0000250|UniProtKB:P53816};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-octadecanoyl-2-hexadecanoyl-sn-glycero-3-phosphocholine +
CC         H2O = 1-octadecanoyl-sn-glycero-3-phosphocholine + H(+) +
CC         hexadecanoate; Xref=Rhea:RHEA:56440, ChEBI:CHEBI:7896,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:73858,
CC         ChEBI:CHEBI:75026; Evidence={ECO:0000250|UniProtKB:P53816};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:56441;
CC         Evidence={ECO:0000250|UniProtKB:P53816};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-octadecanoyl-2-hexadecanoyl-sn-glycero-3-phosphocholine +
CC         H2O = 2-hexadecanoyl-sn-glycero-3-phosphocholine + H(+) +
CC         octadecanoate; Xref=Rhea:RHEA:56444, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:25629, ChEBI:CHEBI:75026,
CC         ChEBI:CHEBI:76078; Evidence={ECO:0000250|UniProtKB:P53816};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:56445;
CC         Evidence={ECO:0000250|UniProtKB:P53816};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-
CC         phosphocholine + H2O = (9Z,12Z)-octadecadienoate + 1-hexadecanoyl-sn-
CC         glycero-3-phosphocholine + H(+); Xref=Rhea:RHEA:40811,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:30245,
CC         ChEBI:CHEBI:72998, ChEBI:CHEBI:73002;
CC         Evidence={ECO:0000250|UniProtKB:P53816};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:40812;
CC         Evidence={ECO:0000250|UniProtKB:P53816};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-
CC         phosphocholine + H2O = 2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-
CC         phosphocholine + H(+) + hexadecanoate; Xref=Rhea:RHEA:40971,
CC         ChEBI:CHEBI:7896, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:73002, ChEBI:CHEBI:76084;
CC         Evidence={ECO:0000250|UniProtKB:P53816};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:40972;
CC         Evidence={ECO:0000250|UniProtKB:P53816};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1,2-di-(9Z-octadecenoyl)-sn-glycero-3-phosphocholine + H2O =
CC         (9Z)-octadecenoate + 2-(9Z-octadecenoyl)-sn-glycero-3-phosphocholine
CC         + H(+); Xref=Rhea:RHEA:56448, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:30823, ChEBI:CHEBI:74669, ChEBI:CHEBI:76071;
CC         Evidence={ECO:0000250|UniProtKB:P53816};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:56449;
CC         Evidence={ECO:0000250|UniProtKB:P53816};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1,2-dihexadecanoyl-sn-glycero-3-phosphocholine + H2O = H(+) +
CC         hexadecanoate + hexadecanoyl-sn-glycero-3-phosphocholine;
CC         Xref=Rhea:RHEA:41384, ChEBI:CHEBI:7896, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:64563, ChEBI:CHEBI:72999;
CC         Evidence={ECO:0000250|UniProtKB:P53816};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:41385;
CC         Evidence={ECO:0000250|UniProtKB:P53816};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1,2-di-(9Z-octadecenoyl)-sn-glycero-3-phosphocholine + H2O =
CC         (9Z)-octadecenoate + a 1-(9Z-octadecenoyl)-sn-glycero-3-
CC         phosphocholine + H(+); Xref=Rhea:RHEA:40923, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:28610, ChEBI:CHEBI:30823,
CC         ChEBI:CHEBI:74669; Evidence={ECO:0000250|UniProtKB:P53816};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:40924;
CC         Evidence={ECO:0000250|UniProtKB:P53816};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1,2-di-(9Z-octadecenoyl)-sn-glycero-3-phosphoethanolamine +
CC         1,2-dihexadecanoyl-sn-glycero-3-phosphocholine = H(+) + hexadecanoyl-
CC         sn-glycero-3-phosphocholine + N-hexadecanoyl-1,2-di-(9Z-
CC         octadecenoyl)-sn-glycero-3-phosphoethanolamine; Xref=Rhea:RHEA:41360,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:64563, ChEBI:CHEBI:72999,
CC         ChEBI:CHEBI:74986, ChEBI:CHEBI:78097;
CC         Evidence={ECO:0000250|UniProtKB:P53817};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:41361;
CC         Evidence={ECO:0000250|UniProtKB:P53817};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1,2-di-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine +
CC         H2O = (9Z,12Z)-octadecadienoate + 1-(9Z,12Z)-octadecadienoyl-sn-
CC         glycero-3-phosphocholine + H(+); Xref=Rhea:RHEA:56428,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:28733,
CC         ChEBI:CHEBI:30245, ChEBI:CHEBI:42027;
CC         Evidence={ECO:0000250|UniProtKB:Q8R3U1};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:56429;
CC         Evidence={ECO:0000250|UniProtKB:Q8R3U1};
CC   -!- SUBUNIT: Interacts with PPP2R1A; this interaction might decrease PP2A
CC       activity. {ECO:0000250|UniProtKB:P53816}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000250|UniProtKB:P53817};
CC       Single-pass membrane protein {ECO:0000255}. Cytoplasm
CC       {ECO:0000250|UniProtKB:P53816}. Cytoplasm, perinuclear region
CC       {ECO:0000250|UniProtKB:Q8R3U1}. Peroxisome membrane
CC       {ECO:0000250|UniProtKB:Q8R3U1}.
CC   -!- SIMILARITY: Belongs to the H-rev107 family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; CR860689; CAH92805.1; -; mRNA.
DR   RefSeq; NP_001128980.1; NM_001135508.1.
DR   BMRB; Q5R611; -.
DR   SMR; Q5R611; -.
DR   STRING; 9601.ENSPPYP00000004679; -.
DR   GeneID; 100190820; -.
DR   KEGG; pon:100190820; -.
DR   CTD; 11145; -.
DR   eggNOG; ENOG502S0JN; Eukaryota.
DR   InParanoid; Q5R611; -.
DR   OMA; VISANCE; -.
DR   OrthoDB; 1602481at2759; -.
DR   Proteomes; UP000001595; Unplaced.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0005778; C:peroxisomal membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005777; C:peroxisome; ISS:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0052740; F:1-acyl-2-lysophosphatidylserine acylhydrolase activity; IEA:UniProtKB-EC.
DR   GO; GO:0016410; F:N-acyltransferase activity; ISS:UniProtKB.
DR   GO; GO:0052739; F:phosphatidylserine 1-acylhydrolase activity; IEA:UniProtKB-EC.
DR   GO; GO:0008970; F:phospholipase A1 activity; ISS:UniProtKB.
DR   GO; GO:0004623; F:phospholipase A2 activity; ISS:UniProtKB.
DR   GO; GO:0102567; F:phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine); IEA:UniProtKB-EC.
DR   GO; GO:0102568; F:phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine); IEA:UniProtKB-EC.
DR   GO; GO:0046485; P:ether lipid metabolic process; ISS:UniProtKB.
DR   GO; GO:0016042; P:lipid catabolic process; ISS:UniProtKB.
DR   GO; GO:0070292; P:N-acylphosphatidylethanolamine metabolic process; ISS:UniProtKB.
DR   GO; GO:0007031; P:peroxisome organization; ISS:UniProtKB.
DR   GO; GO:1904177; P:regulation of adipose tissue development; ISS:UniProtKB.
DR   GO; GO:0006641; P:triglyceride metabolic process; ISS:UniProtKB.
DR   InterPro; IPR007053; LRAT_dom.
DR   Pfam; PF04970; LRAT; 1.
DR   PROSITE; PS51934; LRAT; 1.
PE   2: Evidence at transcript level;
KW   Cell membrane; Cytoplasm; Hydrolase; Lipid degradation; Lipid metabolism;
KW   Membrane; Peroxisome; Reference proteome; Transferase; Transmembrane;
KW   Transmembrane helix.
FT   CHAIN           1..162
FT                   /note="Phospholipase A and acyltransferase 3"
FT                   /id="PRO_0000152486"
FT   TOPO_DOM        1..133
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        134..154
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        155..162
FT                   /note="Lumenal"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          13..129
FT                   /note="LRAT"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01283"
FT   ACT_SITE        23
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01283"
FT   ACT_SITE        35
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01283"
FT   ACT_SITE        113
FT                   /note="Acyl-thioester intermediate"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01283"
SQ   SEQUENCE   162 AA;  17909 MW;  C402BFC756A6DA24 CRC64;
     MRAPIPEPKP GDLIEIFRPF YRHWAIYVGD GYVVHLAPPS EVAGAGAASV MSALTDKAIV
     KKELLYDVAG SDKYQVNNKH DDKYSPLPCS KIIQRAEELV GQEVLYKLTS ENCEHFVNEL
     RYGVARSDQV RDVIIAASAA GMGLAAMSLI GVMFSRNKRQ KQ
//
